Risultati per "economia" in Medicina e industria sanitaria

Es imposible calcular el alcance exacto de la crisis del Coronavirus en nuestra economía, salud y forma de vida a partir de ahora. Lo único que sabemos es que salimos a un mundo distinto al que hemos conocido, y eso no tiene que ser necesariamente malo. Para vivir esta nueva era llena de desafíos, 20 maestros nos dan, cada cual desde su campo, un kit de supervivencia para vivir de forma proactiva, optimista y sin miedo.

A bold new remedy for the sprawling and wasteful health care industry. In this provocative book, Jonathan Bush, cofounder and CEO of athenahealth, calls for a revolution in health care to give customers more choices, freedom, power, and information, and at far lower prices.

The poor die sooner. Blacks die sooner. And poor urban Blacks die sooner than almost all other Americans. David Ansell has spent nearly four decades as a doctor at hospitals serving some of the poorest communities in Chicago, and has witnessed firsthand the lives behind these devastating statistics. In

The Death Gap, he gives a grim survey of these realities, drawn from observations and stories of his patients.

Popular progressive radio host and New York Times best-selling author Thom Hartmann reveals how and why attempts to establish affordable universal healthcare in the United States have been thwarted and what we can do to finally make it a reality.

Antibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Resistance develops because the bacteria that antibiotics target can evolve ways to defend themselves against these drugs. When antibiotics fail, there is very little else to prevent an infection from spreading. Unnecessary use of antibiotics in both humans and animals accelerates the evolution of drug-resistant bacteria, with potentially catastrophic personal and global consequences.

An interesting public health paradox has emerged in some developing nations. Despite government commitment to eradicating noncommunicable diseases and innovative prevention programs aimed at reducing obesity and type 2 diabetes, sugary beverage and fast food industries are thriving. But political leaders in countries such as Mexico, Brazil, India, China, and Indonesia are reluctant to introduce policies regulating the marketing and sale of their products. Why? Eduardo J. Gomez argues that the challenge lies with the strategic politics of junk food industries in these countries.

Life expectancy in the United States has recently fallen for three years in a row - a reversal not seen since 1918 or in any other wealthy nation in modern times. In the past two decades, deaths of despair from suicide, drug overdose, and alcoholism have risen dramatically, and now claim hundreds of thousands of American lives each year - and they're still rising. Case and Deaton, known for first sounding the alarm about deaths of despair, explain the overwhelming surge in these deaths and shed light on the social and economic forces that are making life harder for the working class.

How has the United States, with more resources than any nation, developed a healthcare system that delivers much poorer results, at near double the cost of any other developed country - such that legendary seer Warren Buffett calls the Medical Industrial Complex "the tapeworm of American economic competitiveness"?

In The Body Economic, Stuckler and Basu mine data from around the globe and throughout history to show how government policy becomes a matter of life and death during financial crises. In a series of historical case studies stretching from 1930s America, to Russia and Indonesia in the 1990s, to present-day Greece, Britain, Spain, and the U.S., Stuckler and Basu reveal that governmental mismanagement of financial strife has resulted in a grim array of human tragedies.

Alles begann mit einer Doktorarbeit und der Entdeckung des medizinischen Potenzials des Botenmoleküls messenger RNA. Am Ende stehen prominente Investoren wie Dietmar Hopp oder die Gates-Stiftung, Hunderte Millionen staatlicher Finanzierung, der Aufstieg zum Börsenstar und zum erfolgreichen Impfstoffentwickler. Dazwischen liegt ein steiniger Weg auf der Suche nach Unterstützung. Biotech-Unternehmer Wolfgang Klein hat die Anfangszeit als Finanzchef von CureVac selbst miterlebt. Er erzählt die einzigartige und anekdotenreiche Geschichte auf dem Weg zum Weltunternehmen.

Remaking a Life uses the HIV/AIDS epidemic as a lens to understand how women generate radical improvements in their social well being in the face of social stigma and economic disadvantage. Drawing on interviews with nationally recognized AIDS activists as well as over one hundred Chicago-based women living with HIV/AIDS, Celeste Watkins-Hayes takes listeners on an uplifting journey through women’s transformative projects, a multidimensional process in which women shift their approach to their physical, social, economic, and political survival.

Throughout her recent bout with breast cancer, Letty Cottin Pogrebin became fascinated by her friends’ and family’s diverse reactions to her and her illness: how awkwardly some of them behaved, how some misspoke or misinterpreted her needs, and how wonderful it was when people read her right. She began talking to her fellow patients and dozens of other veterans of serious illness, seeking to discover what sick people wished their friends knew about how best to comfort, help, and even simply talk to them.

Seine Idee rettet Millionen Menschenleben. Im Jahr 1999 macht Ingmar Hoerr als Doktorand in einem Tübinger Labor eine überraschende Entdeckung: mRNA funktioniert als Impfstoff. Über zwanzig Jahre später schützt sich die Welt mit eben solchen mRNA-Impfstoffen vor dem Coronavirus: mit den Vakzinen von BioNTech, Moderna und CureVac. Zwischen Experiment und Triumph liegen zwei Jahrzehnte hartnäckigen Forschens. Mehrfach wäre Ingmar Hoerr mit CureVac fast gescheitert, hätte er nicht Dietmar Hopp, Bill Gates und Elon Musk von seiner Vision überzeugt.